You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTCT Exercise Disclosure
Boulding Mark Elliott · SEC Form 4 · Filed Aug 19, 2026
Exercise
Calculated transaction value
$0
Boulding Mark Elliott Exec. VP And CLO
PTCT
PTC Therapeutics
PTCT
Transaction date
Aug 17, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 2 days later
PTCT daily price context
Close on/before transaction
$72.88
Aug 17, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 2,813 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001578852-26-000022
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$276.39K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Exercise | Aug 17, 2026 | $72.27K |
| Ptc Therapeutics, Inc. PTCT | Sale | Aug 17, 2026 | $133.49K |
| Ptc Therapeutics, Inc. PTCT | Sale | Aug 17, 2026 | $70.64K |
| Ptc Therapeutics, Inc. PTCT Current | Exercise | Aug 17, 2026 | $0 |